Format

Send to

Choose Destination
Surg Pathol Clin. 2018 Jun;11(2):351-366. doi: 10.1016/j.path.2018.02.007. Epub 2018 Mar 26.

Hepatic Adenomas: Classification, Controversies, and Consensus.

Author information

1
Department of Laboratory Medicine and Pathology, 100 1st SE, Rochester, MN 55905, USA. Electronic address: Torbenson.michael@mayo.edu.

Abstract

Rapid advances in molecular and anatomic pathology have greatly improved our understanding of hepatocellular adenomas. Principle among them is a clinically relevant, histology-based classification that identifies hepatic adenomas at greatest risk for malignant transformation. This new classification system has led to general consensus on the major subtypes of hepatic adenomas. However, controversy remains regarding how to incorporate less common types of hepatic adenomas into the classification system and how to incorporate adenoma subtyping into clinical care. This article provides an in-depth review of how adenomas are classified, with a focus on the current rationale, the consensus, and controversies.

KEYWORDS:

Androgen adenoma; Beta-catenin activated adenoma; Classification; HNF1 alpha inactivated adenoma; Hepatic adenoma; Heptaocellular adenoma; Histology; Inflammatory adenoma; Malignant transformation; Myxoid adenoma; Pathology; Pigmented adenoma

PMID:
29751879
DOI:
10.1016/j.path.2018.02.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center